BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35313921)

  • 1. Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy.
    Zhai R; Lyu Y; Ni M; Kong F; Du C; Hu C; Ying H
    Radiat Oncol; 2022 Mar; 17(1):57. PubMed ID: 35313921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma.
    Lee V; Chan SY; Choi CW; Kwong D; Lam KO; Tong CC; Sze CK; Ng S; Leung TW; Lee A
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e52-60. PubMed ID: 27235379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
    Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
    Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
    Lertbutsayanukul C; Kitpanit S; Prayongrat A; Kannarunimit D; Netsawang B; Chakkabat C
    J Radiat Res; 2018 Jul; 59(4):446-455. PubMed ID: 29750261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
    Sommat K; Ong WS; Hussain A; Soong YL; Tan T; Wee J; Fong KW
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):574-580. PubMed ID: 28581397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma: Clinical and dosimetric predictors in a prospective cohort study.
    Zhai RP; Kong FF; Du CR; Hu CS; Ying HM
    Oral Oncol; 2017 May; 68():44-49. PubMed ID: 28438291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid V
    Zhou L; Chen J; Shen W; Chen ZL; Huang S; Tao CJ; Chen M; Yu ZH; Chen YY
    Radiat Oncol; 2020 Mar; 15(1):68. PubMed ID: 32293496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy.
    Chyan A; Chen J; Shugard E; Lambert L; Quivey JM; Yom SS
    Radiat Oncol; 2014 Dec; 9():269. PubMed ID: 25476839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT).
    Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
    Am J Clin Oncol; 2017 Aug; 40(4):413-417. PubMed ID: 25503434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of early thyroid dysfunction after definitive radiotherapy in nasopharyngeal carcinoma patients.
    Lian CL; Zhuo RG; Zhou R; Yu YF; Zhou P; Lin Q; Wu SG
    Head Neck; 2023 Sep; 45(9):2344-2354. PubMed ID: 37415457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy.
    Lin Z; Yang Z; He B; Wang D; Gao X; Tam SY; Wu VWC
    PLoS One; 2018; 13(7):e0200310. PubMed ID: 29985952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial.
    Xu Y; Peng H; Su G; Cheng Y; Guo Q; Guo L; Peng XE; Ke J
    Radiat Oncol; 2023 Aug; 18(1):141. PubMed ID: 37626342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose.
    Zhu MY; Wu HJ; Miao JJ; Di MP; Chen BY; Huang HG; Mai HQ; Wang L; Zhao C
    Oral Oncol; 2021 Sep; 120():105378. PubMed ID: 34174518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.
    Peng L; Mao YP; Huang CL; Guo R; Ma J; Wen WP; Tang LL
    Front Oncol; 2020; 10():551255. PubMed ID: 33102218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma.
    Huang S; Wang X; Hu C; Ying H
    Med Oncol; 2013 Dec; 30(4):710. PubMed ID: 23999842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes.
    Chow JCH; Lui JCF; Cheung KM; Tam AHP; Lam MHC; Yuen TYS; Lee FKH; Leung AKC; Au KH; Ng WT; Lee AWM; Kwan CK; Yiu HHY
    Radiother Oncol; 2022 Dec; 177():105-110. PubMed ID: 36336109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.
    Pinnix CC; Cella L; Andraos TY; Ayoub Z; Milgrom SA; Gunther J; Thosani S; Wogan C; Conson M; D'Avino V; Oki Y; Fanale M; Lee HJ; Neelapu S; Fayad L; Hagemeister F; Rodriguez MA; Nastoupil LJ; Nieto Y; Qiao W; Pacelli R; Dabaja B
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):530-540. PubMed ID: 29681481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
    Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
    BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review.
    Chow JCH; Cheung KM; Cheung GTC; Tam AHP; Lui JCF; Lee FKH; Au KH; Ng WT; Lee AWM; Yiu HHY
    Clin Transl Radiat Oncol; 2022 Mar; 33():83-92. PubMed ID: 35128087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era.
    Wongwattananard S; Prayongrat A; Srimaneekarn N; Hayter A; Sophonphan J; Kiatsupaibul S; Veerabulyarith P; Rakvongthai Y; Ritlumlert N; Kitpanit S; Kannarunimit D; Lertbutsayanukul C; Chakkabat C
    J Radiat Res; 2024 Jan; 65(1):119-126. PubMed ID: 37996086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.